The global market for Dual Biomarker Assay was valued at US$ 1425 million in the year 2024 and is projected to reach a revised size of US$ 2818 million by 2031, growing at a CAGR of 10.1% during the forecast period.

Dual Biomarker Assay Market

A Dual Biomarker Assay is an in vitro diagnostic technique designed to simultaneously detect two biomarkers in biological fluids or tissue samples, widely applied in early disease screening, precise diagnosis, and therapeutic monitoring. The technology employs high-sensitivity immunoassays, molecular detection, or microarray platforms to enable simultaneous quantitative or qualitative analysis of two target molecules, enhancing the specificity and accuracy of disease detection. Dual biomarker assays are commonly used in oncology, cardiovascular diseases, infectious diseases, and chronic conditions, providing clinicians with more reliable reference data and supporting individualized medical and precision therapy decisions. With the increasing diversification of clinical diagnostic needs and rapid advancements in molecular testing technologies, dual biomarker assays are transitioning from laboratory research to commercialized and standardized applications, becoming a crucial component within precision medicine and intelligent diagnostic systems.

The dual biomarker assay market is driven by precision medicine, chronic disease management, and growing demand for early screening. The high prevalence of cancer and cardiovascular diseases has made combined biomarker detection a key tool for improving early diagnostic rates. Government and healthcare policies encouraging innovative diagnostic technologies in primary care and community hospitals expand the application space for high-sensitivity, rapid, and user-friendly dual biomarker assay products. Corporate reports indicate that products with high specificity, compatibility with POCT platforms, and smart data management are more likely to establish strong market presence. Moreover, the adoption of digital health and laboratory information systems enables standardized data, remote transmission, and big data analytics, providing continuous momentum for market growth and product innovation.

Despite promising growth, the industry faces challenges including technical complexity, stringent regulatory approvals, and high R&D investment. Dual biomarker assay products involve highly integrated biological reagents, microfluidic chips, and analyzers, with strict production and quality control requirements. Regulatory pathways vary across countries, extending time-to-market. Company reports highlight that raw material price fluctuations, supply chain instability, and patent barriers may increase operational risks. Additionally, highly commoditized low-end products could compress margins for mid- and high-end innovative solutions, affecting sustained R&D investment.

Downstream demand is increasingly precision-driven and scenario-specific. Hospitals and diagnostic laboratories require high reliability, sensitivity, and traceability; primary and community healthcare settings seek user-friendly, rapid-result products that integrate easily with existing POCT systems; research institutions and pharmaceutical companies demand dual biomarker assays for drug development, efficacy evaluation, and clinical trials. Brokerage and industry reports indicate that digitally connected products with automated sample processing and data analysis will serve as key entry devices in the precision medicine ecosystem.

Key upstream materials for dual biomarker assays include high-specificity antibodies, nucleic acid probes, microfluidic chips, consumables, and analyzer components. Suppliers must comply with ISO 13485 and GMP quality standards to ensure biosafety and consistency. Companies are adopting biodegradable materials and green manufacturing processes in line with sustainability initiatives. Advances in microfluidic technology and automated instruments make high-precision molds, precision manufacturing, and stable supply chains critical competitive factors. Material innovation, supply chain security, and technological scalability have become core determinants of market leadership.

This report aims to provide a comprehensive presentation of the global market for Dual Biomarker Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dual Biomarker Assay.

The Dual Biomarker Assay market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dual Biomarker Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, by Sample and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dual Biomarker Assay companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Dual Biomarker Assay Market Report

Report Metric	Details
Report Name	Dual Biomarker Assay Market
Accounted market size in year	US$ 1425 million
Forecasted market size in 2031	US$ 2818 million
CAGR	10.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Immunoassay-based Molecular-based
Segment by Sample	Blood/Plasma Urine Saliva/Oral Fluid Other
Segment by Purpose of Testing	Early Screening Diagnostic Confirmation Therapeutic Monitoring Other
Segment by Application	Hospital Third-party Laboratory Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Illumina, Fujirebio, Thermo Fisher Scientific, Merck, QIAGEN, Abcam, Agilent Technologie, Bio-Rad Laboratories, Abbott
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Sample etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dual Biomarker Assay company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Dual Biomarker Assay Market growing?

Ans: The Dual Biomarker Assay Market witnessing a CAGR of 10.1% during the forecast period 2025-2031.

What is the Dual Biomarker Assay Market size in 2031?

Ans: The Dual Biomarker Assay Market size in 2031 will be US$ 2818 million.

Who are the main players in the Dual Biomarker Assay Market report?

Ans: The main players in the Dual Biomarker Assay Market are Roche, Illumina, Fujirebio, Thermo Fisher Scientific, Merck, QIAGEN, Abcam, Agilent Technologie, Bio-Rad Laboratories, Abbott

What are the Application segmentation covered in the Dual Biomarker Assay Market report?

Ans: The Applications covered in the Dual Biomarker Assay Market report are Hospital, Third-party Laboratory, Other

What are the Type segmentation covered in the Dual Biomarker Assay Market report?

Ans: The Types covered in the Dual Biomarker Assay Market report are Immunoassay-based, Molecular-based

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Dual Biomarker Assay Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Immunoassay-based

1.2.3 Molecular-based

1.3 Market by Sample

1.3.1 Global Dual Biomarker Assay Market Size Growth Rate by Sample: 2020 VS 2024 VS 2031

1.3.2 Blood/Plasma

1.3.3 Urine

1.3.4 Saliva/Oral Fluid

1.3.5 Other

1.4 Market by Purpose of Testing

1.4.1 Global Dual Biomarker Assay Market Size Growth Rate by Purpose of Testing: 2020 VS 2024 VS 2031

1.4.2 Early Screening

1.4.3 Diagnostic Confirmation

1.4.4 Therapeutic Monitoring

1.4.5 Other

1.5 Market by Application

1.5.1 Global Dual Biomarker Assay Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Hospital

1.5.3 Third-party Laboratory

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Dual Biomarker Assay Market Perspective (2020-2031)

2.2 Global Dual Biomarker Assay Growth Trends by Region

2.2.1 Global Dual Biomarker Assay Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Dual Biomarker Assay Historic Market Size by Region (2020-2025)

2.2.3 Dual Biomarker Assay Forecasted Market Size by Region (2026-2031)

2.3 Dual Biomarker Assay Market Dynamics

2.3.1 Dual Biomarker Assay Industry Trends

2.3.2 Dual Biomarker Assay Market Drivers

2.3.3 Dual Biomarker Assay Market Challenges

2.3.4 Dual Biomarker Assay Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Dual Biomarker Assay Players by Revenue

3.1.1 Global Top Dual Biomarker Assay Players by Revenue (2020-2025)

3.1.2 Global Dual Biomarker Assay Revenue Market Share by Players (2020-2025)

3.2 Global Top Dual Biomarker Assay Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Dual Biomarker Assay Revenue

3.4 Global Dual Biomarker Assay Market Concentration Ratio

3.4.1 Global Dual Biomarker Assay Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Dual Biomarker Assay Revenue in 2024

3.5 Global Key Players of Dual Biomarker Assay Head office and Area Served

3.6 Global Key Players of Dual Biomarker Assay, Product and Application

3.7 Global Key Players of Dual Biomarker Assay, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Dual Biomarker Assay Breakdown Data by Type

4.1 Global Dual Biomarker Assay Historic Market Size by Type (2020-2025)

4.2 Global Dual Biomarker Assay Forecasted Market Size by Type (2026-2031)

5 Dual Biomarker Assay Breakdown Data by Application

5.1 Global Dual Biomarker Assay Historic Market Size by Application (2020-2025)

5.2 Global Dual Biomarker Assay Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Dual Biomarker Assay Market Size (2020-2031)

6.2 North America Dual Biomarker Assay Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Dual Biomarker Assay Market Size by Country (2020-2025)

6.4 North America Dual Biomarker Assay Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Dual Biomarker Assay Market Size (2020-2031)

7.2 Europe Dual Biomarker Assay Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Dual Biomarker Assay Market Size by Country (2020-2025)

7.4 Europe Dual Biomarker Assay Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Dual Biomarker Assay Market Size (2020-2031)

8.2 Asia-Pacific Dual Biomarker Assay Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Dual Biomarker Assay Market Size by Region (2020-2025)

8.4 Asia-Pacific Dual Biomarker Assay Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Dual Biomarker Assay Market Size (2020-2031)

9.2 Latin America Dual Biomarker Assay Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Dual Biomarker Assay Market Size by Country (2020-2025)

9.4 Latin America Dual Biomarker Assay Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Dual Biomarker Assay Market Size (2020-2031)

10.2 Middle East & Africa Dual Biomarker Assay Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Dual Biomarker Assay Market Size by Country (2020-2025)

10.4 Middle East & Africa Dual Biomarker Assay Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Dual Biomarker Assay Introduction

11.1.4 Roche Revenue in Dual Biomarker Assay Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Illumina

11.2.1 Illumina Company Details

11.2.2 Illumina Business Overview

11.2.3 Illumina Dual Biomarker Assay Introduction

11.2.4 Illumina Revenue in Dual Biomarker Assay Business (2020-2025)

11.2.5 Illumina Recent Development

11.3 Fujirebio

11.3.1 Fujirebio Company Details

11.3.2 Fujirebio Business Overview

11.3.3 Fujirebio Dual Biomarker Assay Introduction

11.3.4 Fujirebio Revenue in Dual Biomarker Assay Business (2020-2025)

11.3.5 Fujirebio Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Details

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Dual Biomarker Assay Introduction

11.4.4 Thermo Fisher Scientific Revenue in Dual Biomarker Assay Business (2020-2025)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Dual Biomarker Assay Introduction

11.5.4 Merck Revenue in Dual Biomarker Assay Business (2020-2025)

11.5.5 Merck Recent Development

11.6 QIAGEN

11.6.1 QIAGEN Company Details

11.6.2 QIAGEN Business Overview

11.6.3 QIAGEN Dual Biomarker Assay Introduction

11.6.4 QIAGEN Revenue in Dual Biomarker Assay Business (2020-2025)

11.6.5 QIAGEN Recent Development

11.7 Abcam

11.7.1 Abcam Company Details

11.7.2 Abcam Business Overview

11.7.3 Abcam Dual Biomarker Assay Introduction

11.7.4 Abcam Revenue in Dual Biomarker Assay Business (2020-2025)

11.7.5 Abcam Recent Development

11.8 Agilent Technologie

11.8.1 Agilent Technologie Company Details

11.8.2 Agilent Technologie Business Overview

11.8.3 Agilent Technologie Dual Biomarker Assay Introduction

11.8.4 Agilent Technologie Revenue in Dual Biomarker Assay Business (2020-2025)

11.8.5 Agilent Technologie Recent Development

11.9 Bio-Rad Laboratories

11.9.1 Bio-Rad Laboratories Company Details

11.9.2 Bio-Rad Laboratories Business Overview

11.9.3 Bio-Rad Laboratories Dual Biomarker Assay Introduction

11.9.4 Bio-Rad Laboratories Revenue in Dual Biomarker Assay Business (2020-2025)

11.9.5 Bio-Rad Laboratories Recent Development

11.10 Abbott

11.10.1 Abbott Company Details

11.10.2 Abbott Business Overview

11.10.3 Abbott Dual Biomarker Assay Introduction

11.10.4 Abbott Revenue in Dual Biomarker Assay Business (2020-2025)

11.10.5 Abbott Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Illumina Inc

Fujirebio

Thermo Fisher Scientific

List of Tables

Table 1. Global Dual Biomarker Assay Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Immunoassay-based

Table 3. Key Players of Molecular-based

Table 4. Global Dual Biomarker Assay Market Size Growth Rate by Sample (US$ Million): 2020 VS 2024 VS 2031

Table 5. Key Players of Blood/Plasma

Table 6. Key Players of Urine

Table 7. Key Players of Saliva/Oral Fluid

Table 8. Key Players of Other

Table 9. Global Dual Biomarker Assay Market Size Growth Rate by Purpose of Testing (US$ Million): 2020 VS 2024 VS 2031

Table 10. Key Players of Early Screening

Table 11. Key Players of Diagnostic Confirmation

Table 12. Key Players of Therapeutic Monitoring

Table 13. Key Players of Other

Table 14. Global Dual Biomarker Assay Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 15. Global Dual Biomarker Assay Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 16. Global Dual Biomarker Assay Market Size by Region (2020-2025) & (US$ Million)

Table 17. Global Dual Biomarker Assay Market Share by Region (2020-2025)

Table 18. Global Dual Biomarker Assay Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 19. Global Dual Biomarker Assay Market Share by Region (2026-2031)

Table 20. Dual Biomarker Assay Market Trends

Table 21. Dual Biomarker Assay Market Drivers

Table 22. Dual Biomarker Assay Market Challenges

Table 23. Dual Biomarker Assay Market Restraints

Table 24. Global Dual Biomarker Assay Revenue by Players (2020-2025) & (US$ Million)

Table 25. Global Dual Biomarker Assay Market Share by Players (2020-2025)

Table 26. Global Top Dual Biomarker Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dual Biomarker Assay as of 2024)

Table 27. Ranking of Global Top Dual Biomarker Assay Companies by Revenue (US$ Million) in 2024

Table 28. Global 5 Largest Players Market Share by Dual Biomarker Assay Revenue (CR5 and HHI) & (2020-2025)

Table 29. Global Key Players of Dual Biomarker Assay, Headquarters and Area Served

Table 30. Global Key Players of Dual Biomarker Assay, Product and Application

Table 31. Global Key Players of Dual Biomarker Assay, Date of Enter into This Industry

Table 32. Mergers & Acquisitions, Expansion Plans

Table 33. Global Dual Biomarker Assay Market Size by Type (2020-2025) & (US$ Million)

Table 34. Global Dual Biomarker Assay Revenue Market Share by Type (2020-2025)

Table 35. Global Dual Biomarker Assay Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 36. Global Dual Biomarker Assay Revenue Market Share by Type (2026-2031)

Table 37. Global Dual Biomarker Assay Market Size by Application (2020-2025) & (US$ Million)

Table 38. Global Dual Biomarker Assay Revenue Market Share by Application (2020-2025)

Table 39. Global Dual Biomarker Assay Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 40. Global Dual Biomarker Assay Revenue Market Share by Application (2026-2031)

Table 41. North America Dual Biomarker Assay Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. North America Dual Biomarker Assay Market Size by Country (2020-2025) & (US$ Million)

Table 43. North America Dual Biomarker Assay Market Size by Country (2026-2031) & (US$ Million)

Table 44. Europe Dual Biomarker Assay Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Europe Dual Biomarker Assay Market Size by Country (2020-2025) & (US$ Million)

Table 46. Europe Dual Biomarker Assay Market Size by Country (2026-2031) & (US$ Million)

Table 47. Asia-Pacific Dual Biomarker Assay Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 48. Asia-Pacific Dual Biomarker Assay Market Size by Region (2020-2025) & (US$ Million)

Table 49. Asia-Pacific Dual Biomarker Assay Market Size by Region (2026-2031) & (US$ Million)

Table 50. Latin America Dual Biomarker Assay Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 51. Latin America Dual Biomarker Assay Market Size by Country (2020-2025) & (US$ Million)

Table 52. Latin America Dual Biomarker Assay Market Size by Country (2026-2031) & (US$ Million)

Table 53. Middle East & Africa Dual Biomarker Assay Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 54. Middle East & Africa Dual Biomarker Assay Market Size by Country (2020-2025) & (US$ Million)

Table 55. Middle East & Africa Dual Biomarker Assay Market Size by Country (2026-2031) & (US$ Million)

Table 56. Roche Company Details

Table 57. Roche Business Overview

Table 58. Roche Dual Biomarker Assay Product

Table 59. Roche Revenue in Dual Biomarker Assay Business (2020-2025) & (US$ Million)

Table 60. Roche Recent Development

Table 61. Illumina Company Details

Table 62. Illumina Business Overview

Table 63. Illumina Dual Biomarker Assay Product

Table 64. Illumina Revenue in Dual Biomarker Assay Business (2020-2025) & (US$ Million)

Table 65. Illumina Recent Development

Table 66. Fujirebio Company Details

Table 67. Fujirebio Business Overview

Table 68. Fujirebio Dual Biomarker Assay Product

Table 69. Fujirebio Revenue in Dual Biomarker Assay Business (2020-2025) & (US$ Million)

Table 70. Fujirebio Recent Development

Table 71. Thermo Fisher Scientific Company Details

Table 72. Thermo Fisher Scientific Business Overview

Table 73. Thermo Fisher Scientific Dual Biomarker Assay Product

Table 74. Thermo Fisher Scientific Revenue in Dual Biomarker Assay Business (2020-2025) & (US$ Million)

Table 75. Thermo Fisher Scientific Recent Development

Table 76. Merck Company Details

Table 77. Merck Business Overview

Table 78. Merck Dual Biomarker Assay Product

Table 79. Merck Revenue in Dual Biomarker Assay Business (2020-2025) & (US$ Million)

Table 80. Merck Recent Development

Table 81. QIAGEN Company Details

Table 82. QIAGEN Business Overview

Table 83. QIAGEN Dual Biomarker Assay Product

Table 84. QIAGEN Revenue in Dual Biomarker Assay Business (2020-2025) & (US$ Million)

Table 85. QIAGEN Recent Development

Table 86. Abcam Company Details

Table 87. Abcam Business Overview

Table 88. Abcam Dual Biomarker Assay Product

Table 89. Abcam Revenue in Dual Biomarker Assay Business (2020-2025) & (US$ Million)

Table 90. Abcam Recent Development

Table 91. Agilent Technologie Company Details

Table 92. Agilent Technologie Business Overview

Table 93. Agilent Technologie Dual Biomarker Assay Product

Table 94. Agilent Technologie Revenue in Dual Biomarker Assay Business (2020-2025) & (US$ Million)

Table 95. Agilent Technologie Recent Development

Table 96. Bio-Rad Laboratories Company Details

Table 97. Bio-Rad Laboratories Business Overview

Table 98. Bio-Rad Laboratories Dual Biomarker Assay Product

Table 99. Bio-Rad Laboratories Revenue in Dual Biomarker Assay Business (2020-2025) & (US$ Million)

Table 100. Bio-Rad Laboratories Recent Development

Table 101. Abbott Company Details

Table 102. Abbott Business Overview

Table 103. Abbott Dual Biomarker Assay Product

Table 104. Abbott Revenue in Dual Biomarker Assay Business (2020-2025) & (US$ Million)

Table 105. Abbott Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Dual Biomarker Assay Picture

Figure 2. Global Dual Biomarker Assay Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Dual Biomarker Assay Market Share by Type: 2024 VS 2031

Figure 4. Immunoassay-based Features

Figure 5. Molecular-based Features

Figure 6. Global Dual Biomarker Assay Market Size Comparison by Sample (2020-2031) & (US$ Million)

Figure 7. Blood/Plasma Features

Figure 8. Urine Features

Figure 9. Saliva/Oral Fluid Features

Figure 10. Other Features

Figure 11. Global Dual Biomarker Assay Market Size Comparison by Purpose of Testing (2020-2031) & (US$ Million)

Figure 12. Early Screening Features

Figure 13. Diagnostic Confirmation Features

Figure 14. Therapeutic Monitoring Features

Figure 15. Other Features

Figure 16. Global Dual Biomarker Assay Market Size by Application (2020-2031) & (US$ Million)

Figure 17. Global Dual Biomarker Assay Market Share by Application: 2024 VS 2031

Figure 18. Hospital Case Studies

Figure 19. Third-party Laboratory Case Studies

Figure 20. Other Case Studies

Figure 21. Dual Biomarker Assay Report Years Considered

Figure 22. Global Dual Biomarker Assay Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 23. Global Dual Biomarker Assay Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 24. Global Dual Biomarker Assay Market Share by Region: 2024 VS 2031

Figure 25. Global Dual Biomarker Assay Market Share by Players in 2024

Figure 26. Global Dual Biomarker Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 27. The Top 10 and 5 Players Market Share by Dual Biomarker Assay Revenue in 2024

Figure 28. North America Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. North America Dual Biomarker Assay Market Share by Country (2020-2031)

Figure 30. United States Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Canada Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Europe Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Europe Dual Biomarker Assay Market Share by Country (2020-2031)

Figure 34. Germany Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. France Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. U.K. Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Italy Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Russia Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Ireland Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Dual Biomarker Assay Market Share by Region (2020-2031)

Figure 42. China Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Japan Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. South Korea Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. India Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Australia & New Zealand Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Latin America Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Latin America Dual Biomarker Assay Market Share by Country (2020-2031)

Figure 50. Mexico Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Brazil Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Middle East & Africa Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Middle East & Africa Dual Biomarker Assay Market Share by Country (2020-2031)

Figure 54. Israel Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. UAE Dual Biomarker Assay Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Roche Revenue Growth Rate in Dual Biomarker Assay Business (2020-2025)

Figure 58. Illumina Revenue Growth Rate in Dual Biomarker Assay Business (2020-2025)

Figure 59. Fujirebio Revenue Growth Rate in Dual Biomarker Assay Business (2020-2025)

Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Dual Biomarker Assay Business (2020-2025)

Figure 61. Merck Revenue Growth Rate in Dual Biomarker Assay Business (2020-2025)

Figure 62. QIAGEN Revenue Growth Rate in Dual Biomarker Assay Business (2020-2025)

Figure 63. Abcam Revenue Growth Rate in Dual Biomarker Assay Business (2020-2025)

Figure 64. Agilent Technologie Revenue Growth Rate in Dual Biomarker Assay Business (2020-2025)

Figure 65. Bio-Rad Laboratories Revenue Growth Rate in Dual Biomarker Assay Business (2020-2025)

Figure 66. Abbott Revenue Growth Rate in Dual Biomarker Assay Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions